Preventive effects of p-coumaric acid on cardiac hypertrophy and alterations in electrocardiogram, lipids, and lipoproteins in experimentally induced myocardial infarcted rats

Food and Chemical Toxicology

Volumn 60, Issue , 2013, Pages 348-354

  Roy, Abhro Jyoti ^a   Stanely Mainzen Prince, P ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Electrocardiogram; Isoproterenol; Lipids; Lipoproteins; Myocardial infarction; P Coumaric acid

Indexed keywords

FATTY ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PARA COUMARIC ACID; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG MECHANISM; ELECTROCARDIOGRAPHY; ENZYME ACTIVITY; FATTY ACID BLOOD LEVEL; HEART VENTRICLE HYPERTROPHY; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

ELECTROCARDIOGRAM; ISOPROTERENOL; LIPIDS; LIPOPROTEINS; MYOCARDIAL INFARCTION; P-COUMARIC ACID;

ANIMALS; CARDIOMEGALY; CHOLESTEROL; COUMARIC ACIDS; ELECTROCARDIOGRAPHY; FATTY ACIDS, NONESTERIFIED; HYDROXYMETHYLGLUTARYL COA REDUCTASES; ISOPROTERENOL; LIPOPROTEINS; MALE; MYOCARDIAL INFARCTION; RATS; RATS, WISTAR; TRIGLYCERIDES;

EID: 84883005936     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2013.04.052     Document Type: Article

References (37)

1. Abdel-Wahab M.H., El-Mahdy M.A., Abd-Ellah M.F., Helal G.K., Khalifa F., Hamada F.M.A. Influence of p-coumaric acid on doxorubicin-induced oxidative stress in rat's heart. Pharmacol. Res. 2003, 48:461-465.
2. Brofman P.R., Carvalho K.A., Guarita-Souza L.C., Rebelatto C., Hansen P., Senegaglia A.C., Myague N., Furuta M., Francisco J.C., Olandoski M. Cellular transplant: functional, immunocytochemical and histopathologic analysis in an experimental model of ischemic heart disease using different cells. Braz. J. Cardiovasc. Surg. 2004, 19:261-266.
3. Devika P.T., Stanely Mainzen Prince P. Protective effect of (-) epigallocatechin gallate (EGCG) on lipid peroxide metabolism in isoproterenol induced myocardial infarction in male wistar rats: a histopathological study. Biomed. Pharmacother. 2008, 62:701-708.
4. Esterbauer H., Gebicki J., Puhl H., Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic. Biol. Med. 1992, 13:341-390.
5. Falholt K., Lund B., Falholt W. An easy colorimetric micromethod for routine determination of free fatty acids in plasma. Clin. Chim. Acta 1973, 46:105-111.
6. Ferguson L.R., Zhu S.T., Harris P.J. Antioxidant and antigenotoxic effects of plant cell wall hydroxycinnamic acids in cultured HT-29 cells. Mol. Nutr. Food Res. 2005, 49:585-593.
7. Folch J., Lees M., Sloane S.G.H. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 1957, 226:497-509.
8. Fossati P., Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin. Chem. 1982, 28:2077-2080.
9. Goldman S., Raya T.E. Rat infarct model of myocardial infarction and heart failure. J. Card. Fail. 1995, 1:169-177.
10. Goldstein J.L., Brown M.S. Progress in understanding the LDL receptor and HMG-CoA reductase, two membrane proteins that regulate the plasma cholesterol. J. Lipid Res. 1984, 25:1450-1461.
11. Guarita- Souza L.C., Carvalho K.A., Rebelatto C., Senegaglia A.C., Hansen P., Furuta M., Miyague N., Francisco J.C., Olandoski M., Woitowicz V., Simeoni R., Faria-Neto J.R., Brofman P. Comparison of mononuclear and mesenchymal stem cell transplantation in myocardium infarction. Braz. J. Cardiovasc. Surg. 2005, 20:270-278.
12. Holland R.P., Brooks H. TQ-ST segment mapping: critical review and analysis of current concepts. Am. J. Cardiol. 1977, 40:110-129.
13. Jacksen G. Metabolic agents for stable angina. Heart Metab. 1998, 1:10-11.
14. Jones P., Kafonek S., Laurora I., Hunninghake D. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin and fluvastatin in patients with hypercholesterolemia (The CURVES Study). Am. J. Cardiol. 1998, 81:582-587.
15. Kapoor N.K., Dhawan S., Nityanand S. Isoproterenol induced myocardial necrosis and biogenic amine levels in rats. Indian J. Exp. Biol. 1979, 17:292-294.
16. Lopez Messa J.B., Garmendia Leiza J.R., Aguilar García M.D., Andrés de Llano J.M., Alberola López C., Ardura Fernández J. Cardiovascular risk factors in the circadian rhythm of acute myocardial infarction. Rev. Esp. Cardiol. 2004, 57:850-858.
17. Mensor L.L., Menezes F.S., Leitão G.G., Reis A.S., Dos Santos T.C., Coube C.S., Leitao S.G. Screening Brazilian plant extracts for antioxidant activity by the use of DPPH free radical method. Phytother. Res. 2001, 15:127-130.
18. Morton L.W., Abu-Amsha Caccetta R., Puddey I.B., Croft K.D. Chemistry and biological effects of dietary phenolic compounds: relevance to cardiovascular disease. Clin. Exp. Pharm. Physiol. 2000, 27:152-159.
19. Nair P.S., Shyamala Devi C.S. Efficacy of mangiferin on serum and heart tissue lipids in rats subjected to isoproterenol induced cardio toxicity. Toxicology 2006, 228:135-139.
20. O'Brien P.J., Dameron G.W., Beck M.L., Kang Y.J., Erickson B.K., Di Battista T.H., Miller K.E., Jackson K.N., Mittelstadt S. Cardiac toponin T is a sensitive, specific biomarker of cardiac injury in laboratory animals. Lab. Anim. Sci. 1997, 47:486-495.
21. Patel V., Upaganlawar A., Zalawadia R., Balaraman R. Cardioprotective effect of melatonin against isoproterenol induced myocardial infarction in rats: a biochemical, electrocardiographic and histoarchitectural evaluation. Eur. J. Pharmacol. 2010, 644:160-168.
22. Rajadurai M., Stanely Mainzen Prince P. Preventive effect of naringin on lipids, lipoproteins and lipid metabolic enzymes in isoproterenol - induced myocardial infarction in Wistar rats. J. Biochem. Mol. Toxicol. 2006, 20:191-197.
23. Rao A.V., Ramakrishnan S. Indirect assessment of hydroxymethyl glutaryl-CoA reductase (NADPH) activity in liver tissue. Clin. Chem. 1975, 21:1523-1525.
24. Roy A.J., Stanely Mainzen Prince P. Preventive effects of p-coumaric acid on lysosomal dysfunction and myocardial infarct size in experimentally induced myocardial infarction. Eur. J. Pharmacol. 2013, 699:33-39.
25. Sangeetha T., Darlin Quine S. Preventive effect of s-allyl cysteine sulfoxide (alliin) on cardiac marker enzymes and lipids in isoproterenol-induced myocardial injury. J. Pharm. Pharmacol. 2006, 58:617-623.
26. Scalbert A., Williamson G. Dietary intake and bioavailability of polyphenols. J. Nutr. 2000, 130:2073S-2085S.
27. Sharma R.D. Isoflavones and hypercholesterolemia in rats. Lipids 1979, 14:535-539.
28. Sparagna G.C., Hickson Bick D.L. Cardiac fatty acid metabolism and the induction of apoptosis. Am. J. Med. Sci. 1999, 318:15-21.
29. Stanely Mainzen Prince P. A biochemical, electrocardiographic, electrophoretic, histopathological and in vitro study on the protective effects of (-) epicatechin in isoproterenol-induced myocardial infarcted rats. Eur. J. Pharmacol. 2011, 671:95-101.
30. Stanely Mainzen Prince P., Dhanasekar K., Rajakumar S. Preventive effects of vanillic acid on lipids, bax, bcl-2 and myocardial infarct size on isoproterenol induced myocardial infarcted rats: a biochemical and in vitro study. Cardiovasc. Toxicol. 2011, 11:58-66.
31. Thomes P., Rajendran M., Pasanban B., Rengasamy R. Cardioprotective activity ofCladosiphon okamuranus fucoidan against isoproterenol induced myocardial infarction in rats. Phytomedicine 2010, 18:52-57.
32. Vik-Mo H., Mjos O.D. Influence of free fatty acids on myocardial oxygen consumption and ischemic injury. Am. J. Cardiol. 1981, 48:361-365.
33. Wang J., Bo H., Meng X., Wu Y., Bao Y., Li Y. A simple and fast experimental model of myocardial infarction in the mouse. Tex. Heart Inst. J. 2006, 33:290-293.
34. Wexler B.C., Greenberg B.P. Protective effects of clofibrate on isoproterenol-induced myocardial infarction in arteriosclerotic and non-arteriosclerotic rats. Atherosclerosis 1978, 29:373-375.
35. Yeagle P.L. Cholesterol and the cell membrane. Biochim. Biophys. Acta 1986, 822:267-287.
36. Zhou R., Xu Q., Zheng P., Yan L., Zheng J., Dai G. Cardioprotective effect of fluvastatin on isoproterenol-induced myocardial infarction in rat. Eur. J. Pharmacol. 2008, 586:244-250.
37. Zlatkis A., Zak B., Boyle A.J. A new method for the direct determination of serum cholesterol. J. Lab. Clin. Med. 1953, 41:486-492.